Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Innovate, Integrate & Motivate with Tissue Engineering and Regenerative Medicine
- Regenerative Medicine 2018

Welcome Message

Tissue Engineering and Regenerative Medicine extends the heartiest welcome to proficient delegates, scientists, professors, students, young researchers, business executives, scholars, chemists and professionals across the globe to be a part of  “Global Conference on Tissue Engineering and Regenerative Medicine” on July 30-31, 2018, to be held at Barcelona, Spain. Keynote speech, exhibitions, oral and poster presentations outline the key attractions of the conference on the theme “ Innovate, Integrate & Motivate with Tissue Engineering and Regenerative Medicine”.

Allied Academies organizes Tissue Engineering and Regenerative Medicine 2018 conference along with 300+ Conferences across USA, Europe & Asia every year with support from 1000 more scientific societies and Publishes 400+ Open access journals which contain over 30000 eminent personalities as editorial board members.

We are pleased to invite you to join us at the tissue engineering and regenerative medicine conference 2018, where you will be sure to have a meaningful experience with scholars from around the world. All members of the organizing committee look forward to meeting you in Barcelona, Spain.

Scientific Sessions

Session 1. Tissue Engineering

Tissue engineering is an interdisciplinary course dealing with the building up of new Organs. It reveals us the truth that the nature can be imitated by the evaluation of tissue engineering. It substitutes the biological functions by replacing the replaced or damaged tissues by the combination of cells, organic materials and biochemical factors. It involves implantation, Restoration and regeneration of tissues. The main goal of tissue engineering is to develop the diseased or damaged tissues in a body or Cells attached to ECM (Extra Cellular Matrix).

  • Animal models of tissue regeneration
  • Intrinsic tissue regeneration
  • Guided tissue regeneration
  • Human tissue regeneration
  • In silico tissue engineering

 Session 2. Regenerative Medicine

As we grow older our body parts fail to function in a normal way. Our current Medical technology helps in regenerating the damaged body parts. Many species can regenerate by themselves. For example a Salomon can regrow its limbs, tails etc. whereas in human it is possible only for the liver to regenerate. Thus Regenerative Medicine promises the repair of body parts with their own living tissues by inculcating Scaffolds.

  • Molecular fundamentals of regeneration
  • Treatment models
  • Recapitulating tissue and organ structure 

Session 3. Scaffolds in Tissue Engineering

Scaffolds are Biomaterials coated with our body cells reproducing cartilages, kidneys and even complex Organs like heart and lungs. Scaffolds are a potential to change the way we live. The type of composition depends on Tissue but involves

  • Structural protein- collagen, elastin
  • Adhesive protein- fibronectin, laminin
  • Proteoglycans including polysaccharides and glycosaminoglycans (GAGS) 

Session 4. Biomaterials

 Biologic Tissues consist of the cells, the extracellular matrix (made up of a complex of cell secretions immobilized in spaces continuous with cells), and the signaling systems, which are brought into play through differential activation of Genes or cascades of genes whose secreted or transcriptional products are responsible for cueing tissue building and differentiation. The principal components of scaffolds (into which the extracellular matrix is organized in actual tissues) are collagen Biopolymers, mainly in the form of fibers and fibrils. Other forms of polymer organization have also been used (gels, foams, and membranes) for engineering tissue substitutes. The various forms can be combined in the laboratory to create imitations of biopolymer organization in specific tissues. Scaffolds can be enriched with signaling molecules, which may be bound to them or infused into them.

  • Cell seeding
  • Hydrogels
  • Cell encapsulation and micro encapsulation
  • Biopolymers
  • Biomaterials
  • Cell sheets

 Session 5. Acellular Prosthesis

 The use in Animal models and in humans of complex allogeneic and xenogeneic tissues, depleted of their living cells is by freezing or other methods, has been shown to be immunologically acceptable without the use of  Immunosuppressants. It is known from studies in experimental animals and humans that acellular allogeneic and tissues, many available through tissue banks, is becoming well established. Further, the growing xenogeneic implants have been accepted by their hosts. Acellular collagen matrices, in the form of foams with and without bone precursor minerals, have been used as vehicles for delivering a variety of  Bone

  • Morphogenetic proteins
  • Prosthesis based breast reconstruction
  • Acellular dermal matrices
  • Soft tissue replacement

 Session 6. Stem Cells and its Types

Scaffolds can be populated with adult-derived cells that are capable of undergoing subsequent differentiation after being cultivated in vitro. In this category are cells of the skin, cartilage, muscle, tendon, ligament, bone, adipose tissue, endothelium, and many others. Aside from skin, the foregoing cell types are harbored as stem cell populations in the marrow, in addition to those of the hematopoietic and immune systems, but the diversity of mesenchymal and possibly other cell types in the marrow still needs to be probed. Stimulating factors, the cytokines,which move some of the cells into the circulation, will be important for engineering Acellular Scaffolds. Other stem cells are available to Tissue Engineering, such as the satellite cells found in striated muscle and to some degree keratinocytes of the skin. Where host cells are available, an acellular scaffold, particularly one enhanced with signals and possessing the binding sites needed for cell attachment, can mobilize host cells that will populate the Prosthesis.

  • Cancer stem cells
  • Mesenchymal stem cells
  • Stem cell therapy
  • Hematopoietic stem cells
  • Embryonic stem cells
  • Tissue specific stem cells
  • Induced pluripotent stem cells (IPSC)
  • Amniotic stem cell 

Session 7. Regenerative Treatment Models

The field of Regenerative Medicine encompasses numerous strategies, including the use of materials and de novo generated cells, as well as various combinations thereof, to take the place of missing tissue, effectively replacing it both structurally and functionally, or to contribute to Tissue healing. The body's innate healing response may also be leveraged to promote regeneration, although adult humans possess limited regenerative capacity in comparison with lower vertebrates. This review will first discuss regenerative medicine therapies that have reached the Market. Preclinical and early clinical work to alter the physiological environment of the patient by the introduction of materials, living cells, or growth factors either to replace lost tissue or to enhance the body's innate healing and repair mechanisms will then be reviewed. Strategies for improving the structural sophistication of  Implantable Grafts  and effectively using recently developed cell sources will also be discussed.

  • Tissue remodeling
  • Apoptosis inhibition
  • Cell differentiation
  • 3D tissue printing 

Session 8. Formation of 3D Printing of Biomaterials

The formation of a 3-dimensional structure of  Biomaterials is known as the 3D printing. According to the number of dimensions in nano-scale, the Biomaterials are of three types- 3D (nano-particle), 2D (i.e. nano-fiber), and 1D (nano-sheet). 3D Bio Printing is the creation of various cell patterns by using printing techniques along with the layer-by-layer method to form tissue mimetic structures without any loss in cell function that can be further used in Tissue Engineering. Bio printing helps in the research of drugs and pills by printing tissues and Organs.  It is also used for micro-devices and microarrays. The 3D printing materials market is expected to reach USD 1,409.5 Million by 2021 from USD 580.1 Million in 2017, at a CAGR of 22.60%.

  • High-energy handling of biomaterials
  • Electro Spinning and Allied Technologies
  • In 3D Bio-printing
  • Layer-by-layer: 1, 2 and 3D Nano Assembly
  • Hierarchical Three Dimensional Structures 

Session 9.  Regenerative Medicine Market

There are strong pricing pressures from public healthcare payers globally as Governments try to reduce budget deficits. Regenerative Medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole. The global market for Tissue Engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.  It grows to $135 billion to 2024. The contribution of the European region was 43.3% of the market in 2010, a value of $24.2 billion. The market is expected to reach $25.5 billion by 2011 and will further grow to $36.1 billion by 2016 at a CAGR of 7.2%. It grows to $65 billion to 2024. 

Session 10.  Bone Tissue Engineering

Tissue building of musculoskeletal tissues, especially bone and ligament, is an emerging field. In bone, innovation has focused on bone graft materials and the advancement of biodegradable frameworks. Tissue designing methodologies has included cell and Gene Therapy.

Session 11. 3D Bio-printing Techniques

The 3D Bio-printing uses techniques to combine the cells, growth factors and Biomaterials to reach the maximum imitation. It can print tissues, Organs to incorporate drugs and pills and even scaffolds. It has found a massive use in the field of Regenerative Medicine.

  • Pre-bioprinting
  • Post-bioprinting
  • Biomimicry
  • Mini-tissue
  • Autonomous self-assembly

Session 12.Organ Engineering

 The transplantation of a whole organ with new therapeutic means that may overcome the Drawbacks involved in the current Artificial Organs.  It is an exciting  Research Area that aims at Regenerative Alternatives to harvested tissues for organ transplantation with soft tissues. As a result of the medical and market potential, there is significant academic and corporate interest in this technology.

  • Cellular Interactions
  • Hybrid artificial organs
  • Modeling of Organs
  • Microbial Sterilization
  • Microbial Decontamination 

Session 13. Ethical and Legal Issues 

As a field, Tissue Engineering has been defined for little more than a decade. Much still needs to be learned and developed to provide a firm scientific basis for Therapeutic Application. Up to date, much of the progress in this field has been related to the development of model systems, which have suggested a variety of approaches. Also, certain principles of cell biology and tissue development have been delineated. The field can draw heavily on the explosion of new knowledge from several interrelated well-established disciplines, and, in turn, may promote the coalescence of relatively new, related fields to achieve their potential. The rate of new understanding of complex living systems has been explosive in the past three decades. Tissue engineering can draw on the knowledge gained in the fields of cell biology, biochemistry, and molecular biology and apply it to the engineering of new tissues. Likewise, advances in  Materials Science, chemical engineering, and Bioengineering allow the rational application of engineering principles to living systems. Yet another branch of related knowledge is the area of human therapy as applied by surgeons and physicians.

Session 14. Stem Cell Transplant

Stem Cell Transplantation is a system that is regularly suggested as a treatment choice for individuals with leukemia, different myeloma, and a few sorts of lymphoma. It might likewise be utilized to treat some hereditary sicknesses. In this process diseased bone marrow (the springy, greasy tissue found inside bigger bones) is treated with Chemotherapy as well as radiation Treatment and afterwards replaced with the stem cells. 

Session 15. Embryonic Stem Cells

Embryonic Stem Cells can develop (i.e. separate) into all subsidiaries of the three essential germ layers: ectoderm, endoderm and mesoderm which make them Pluripotent. As such, they can form into each of the more than 200 cell sorts of the grown-up body as long as they are indicated to do as such. They are recognized by two particular properties: their pluripotency, and their capacity to duplicate.

Session 16. Applications in Regenerative Medicine and Tissue Engineering

Advancements in gene editing and Tissue Engineering technology have endorsed the ex vivo remodeling of stem cells grown into 3D Organoids and tissue structures for personalized applications. This review outlines the most recent advancement in transplantation and tissue engineering technologies of ESCs, TSPSCs, MSCs, UCSCs, BMSCs, and iPSCs in Regenerative Medicine. Additionally, this review also discusses stem cells regenerative application in wildlife conservation.

  • Cardiovascular
  • Oncology
  • Musculoskeletal
  • Wound healing
  • Ophtahalmology 

Session 17. Future Scope- Biomedical Technology

Biomedical Innovation guarantees numerous new advancements. Specialists are exploring different avenues regarding various treatment alternatives that utilize Tissue building. Tissue recovery will majorly affect twisted treatment, as patients get recovered tissue to fill in substantial injuries that would be difficult to recuperate in the typical mold. Scarring would be diminished, giving more noteworthy personal satisfaction to patients after calamitous damage. Remade veins could be utilized to enable patients with cardiovascular illness to give better heart to work and a full come back to typical exercises. Liver Tissue from patients could be developed in lab to give methods for testing the most effective pharmaceuticals for treatment, rather than the experimentation strategy being utilized on the patient himself. Later on, entire organs might be developed to give transplant new parts to patients with kidney or heart damage. Athletic wounds to ligament and bone could be repaired all the more quickly with Regrown Tissue from the patient's own body.

Market Analysis


The tissue engineering and regenerative medicine growth is hindered by the development of biomaterials. Over the recent years , the global tissue engineering and regenerative medicine has been growing rapidly owing to the aging population,rising number of people with organ failures and wound healing market. It is also driven by increased investment in research and development.The tissue engineering and regenerative medicine growth is hindered by the development of biomaterials. Over the recent years , the global tissue engineering and regenerative medicine has been growing rapidly owing to the aging population,rising number of people with organ failures and wound healing market. It is also driven by increased investment in research and development.

The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate(CAGR) of 22.3%.

Global translational regenerative medicine market


The Barcelona city in spain stands out in the field of regenerative medicine. The center of regenerative medicine in barcelona was founded in the year 2004 which aimes at the implementation and advancements in the field of regenerative medicine by conduction researches of excellence in the field.

In the year 2009 a new approach made a difference in the real life. In Barcelona ,spain Claudia castillo who was affected by tuberculosis was surviving because of  the difficulties in breathing. A scaffold engineered windpipe was developed and implanted in her body replacing the diseased windpipe. Thus, Barcelona satisfies the emerging needs in the field of regenerative medicine and tissue engineering.

Organizing Committee
OCM Member
Oleksandr Kukuharchuk
Research Director , Stem Cells
ReeLabs Pvt. Ltd
Mumbai, India
OCM Member
Christina Kamma-Lorger
Beamline Scientist
Alba Synchrotron Light Source
Barcelona, Spain
OCM Member
Nehra Beltran
Metropolitan Autonomous University
Mexico, USA
OCM Member
Nafiseh Baheiraei
Tissue Engineering
Faculty of Medical Sciences, Tarbiat Modares University
Tehran, Iran
OCM Member
Dr. Anthi Ranella
Ass. Researcher
Athens, Greece

To Collaborate Scientific Professionals around the World

Conference Date July 30-31, 2018
Speaker Oppurtunity Day 1 Day 2
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Sponsorship Opportunities Click here for Sponsorship Opportunities

Join The Discussion

Allied Academies Global Conference Directory

Copyright © 2018-2019 Allied Academies, All Rights Reserved.